Representatives from Intellijoint Surgical will be attending Current Concepts in Joint Replacement‘s Annual Spring Meeting in Las Vegas, Nevada. Topics during the meeting will cover surgical outcomes, approaches, and challenges for both primary and revision hip arthroplasty. May 20-23, 2018 Aria at City Center Las Vegas, NV
Current Concepts in Joint Replacement (CCJR) – Spring 2018 Meeting Read More »
Intellijoint Surgical® is excited to be exhibiting and providing product demonstrations of intellijoint HIP® can bring precision to orthopedic surgery. Visit us at the upcoming AAOS 2018 Annual Meeting in New Orleans! March 6-10, 2018 Morial Convention Center 900 Convention Center Blvd New Orleans, Louisiana Intellijoint Surgical – Booth #6213
Visit us in New Orleans for AAOS 2018! Read More »
November 01, 2017 (Waterloo, ON) – Intellijoint Surgical®, a medical technology company, is pleased to announce that it has received FDA Clearance for revision Total Hip Arthroplasty (THA) with its intellijoint HIP® System. A 3D Mini-Optical Navigation System, intellijoint HIP® provides surgeons with precise measurements for cup position, leg length and offset for THA. Requiring no pre-operative or intra-operative imaging,
May 3, 2017 (Waterloo, ON) – Intellijoint Surgical® is pleased to welcome Dr. Michael Bradley, MD, MBA, MS, as the newest member to its Scientific Advisory Board (SAB). Dr. Bradley is Chief of Orthopaedics at South County Hospital in Wakefield, Rhode Island, and President/CEO of Ortho Rhode Island. As a board-certified surgeon, he brings 12 years of orthopaedic
Tuesday, April 11, 2017 (Waterloo, ON) – Intellijoint Surgical® is proud to announce that intellijoint HIP® has now – only one year after commercial launch – been used in over 1,000 total hip replacement procedures in the United States, Canada and Australia. intellijoint HIP® is a novel medical device providing 3D mini-optical navigation for orthopaedic surgeons. The one thousandth case
March 7, 2017 (Waterloo, Ontario) – Intellijoint Surgical® Inc., a privately-held Canadian medical technology company, announces FDA clearance of intellijoint HIP® Anterior, the newest application to the intellijoint HIP suite. intellijoint HIP Anterior is a 3D mini-optical navigation solution that provides quantifiable, intraoperative measurements for cup position, leg length, and offset to orthopaedic surgeons performing Direct Anterior Approach (DAA) Total Hip Arthroplasty (THA). “intellijoint HIP Anterior has been
Intellijoint Surgical® Announces intellijoint HIP® Anterior Application FDA Clearance Read More »
Intellijoint Surgical® was featured in the Record’s 2016 Technology Spotlight magazine alongside some of Kitchener-Waterloo’s best tech companies.
Intellijoint Surgical featured in 2016 Technology Spotlight Read More »
Intellijoint Surgical® chats with MedCity News about the recent 11M funding announcement and future growth.
MedCity News’ Feature on Intellijoint Surgical Read More »
From inception to commercialization in less than six years, Intellijoint Surgical® is excited to announce the completion of its Series A fundraising round – the biggest milestone to date. Read Full Press Release Press Release;
Intellijoint Surgical® Raises $11MM to Expand the US Launch of intellijoint HIP® Read More »
